Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Licenses Enhanced Version of ProSight PTM Proteomics Software

ORLANDO, Fla., Feb. 28 (GenomeWeb News) - Thermo Electron has licensed a new commercial version of ProSight PTM, a software developed by the University of Illinois for identifying and characterizing intact proteins and their post-translational modifications, GenomeWeb News has learned.


The software will be released in about six months, according to the software's lead developer, Neil Kelleher, who gave a presentation on ProSight PTM yesterday at the PITTCON conference. Kelleher is an assistant professor of chemistry at the Universityof Illinoisat Urbana-Champaign. GenomeWeb News spoke with Kelleher at the PITTCON meeting, held here this week.


A non-commercial version of ProSight PTM software is currently available for free here. The commercial version will differ from the non-commercial version in the way it performs batch processing, said Kelleher.


In addition, the commercial version of ProSight PTM will include a new method of searching referred to as the biomarker search mode. In this mode, the software specifically searches for protein fragments found in blood and tries to match them with top-down mass-spectrometry data.


"The commercial grade will be a lot more robust in terms of speed and features," Kelleher said.


A representative of Thermo Electron said the company prefers not reveal details about the licensing agreement and costs for ProSight PTM until a later date.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.